Deka Biosciences, Inc. — Form D
Deka Biosciences, Inc. of GERMANTOWN, MD, a company, filed a Form D exempt-offering notice with the SEC on 2023-12-08. The offering totals $41.4M, of which $29.9M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-12-08
- Form: D
- Accession: 0001893069-23-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $41.4M
- Amount sold: $29.9M
- Remaining: $11.5M
- Investors: 33
- Date of first sale: 2023-02-06
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-499203
Issuer
- Name: Deka Biosciences, Inc.
- CIK: 0001893069
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 20378 SENECA MEADOWS PKWY, GERMANTOWN, MD, 20876
- Phone: (301) 569-4323
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| Detlev Biniszkiewicz | Director | Cambridge, MA |
| Peter Buzy | Director | Germantown, MD |
| Rakhshita Dhar | Director | Cambridge, MA |
| Lu Han | Director | Germantown, MD |
| John Mumm | Director | Germantown, MD |
| Pavel Khrimian | Executive Officer | Germantown, MD |
| John Mumm | Executive Officer | Germantown, MD |
| Christopher Yaen | Executive Officer | Germantown, MD |
| Lucio Iannone | Director | Watertown, MA |
| Pavel Khrimian | Director | Germantown, MD |
| Vera Mumm | Executive Officer | Germantown, MD |
| Sally (Yuanheng) Wang | Director | Germantown, MD |
| Christian Kanady | Director | Oklahoma City, OK |
Other filings by this issuer (1)
More